“The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men With Obesity and Insulin Resistance”. Global Scientific Review, vol. 48, Feb. 2026, pp. 42-45, https://scienticreview.com/index.php/gsr/article/view/602.